Target intelligence / Profile preview

Hepatitis C virus NS3-NS4A serine protease complex (HCV NS3-NS4A protease)

Target
HCV NS3-NS4A protease
Molecular classification
Enzyme, Serine protease, Viral protein
01

Overview

The Hepatitis C virus (HCV) NS3-NS4A serine protease complex is a heterodimeric enzyme essential for the viral life cycle. The NS3 protein contains a serine protease domain at its N-terminus, which requires the NS4A protein as a cofactor to achieve full catalytic activity and proper membrane localization (UniProt P26664). This complex is responsible for the proteolytic processing of the HCV polyprotein at the NS3/4A, NS4A/4B, NS4B/5A, and NS5A/5B junctions, a process vital for generating functional viral proteins (Lindenbach & Rice, Nature, 2005). Additionally, the NS3-NS4A protease facilitates immune evasion by cleaving host signaling proteins such as MAVS (mitochondrial antiviral-signaling protein) and TRIF, thereby disrupting the induction of the host's innate antiviral response (Meylan et al., Nature, 2005). Due to its critical role in replication and immune suppression, it is a primary target for direct-acting antiviral (DAA) therapies. Protease inhibitors bind to the enzyme's active site or interfere with the NS3-NS4A interface to halt viral production and restore host immune signaling (AASLD/IDSA HCV Guidance).

Other names
NS3/4A proteaseHCV NS3-NS4A complexHCV serine proteaseNS3 proteaseNS3-NS4A heterodimer
02

Mechanism of action

Inhibition of the NS3-NS4A serine protease activity, preventing the cleavage of the viral polyprotein and blocking viral replication.

03

Biological functions

Viral polyprotein processingViral replicationImmune evasionProteolysis
04

Disease associations

InfectionHepatitis C infectionLiver cirrhosisHepatocellular carcinoma
05

Safety considerations

Drug-drug interactions via CYP3A4 inhibition/inductionDevelopment of drug resistance (RASs)Potential hepatotoxicity in patients with decompensated cirrhosisSkin rash and photosensitivity (specific to early generation inhibitors)
06

Interacting drugs

Telaprevir

6 more in the full profile.

07

Biomarkers

HCV RNA viral loadHCV genotypeResistance-associated substitutions (RASs)

Beyond the preview

Go deeper on Hepatitis C virus NS3-NS4A serine protease complex (HCV NS3-NS4A protease).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hepatitis C virus NS3-NS4A serine protease complex (HCV NS3-NS4A protease).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call